Particle swarm optimization with state-based adaptive velocity limit strategy

Velocity limit (VL) has been widely adopted in many variants of particle swarm optimization (PSO) to prevent particles from searching outside the solution space. Several adaptive VL strategies have been introduced with which the performance of PSO can be improved. However, the existing adaptive VL strategies simply adjust their VL based on iterations, leading to unsatisfactory optimization results because of the incompatibility between VL and the current searching state of particles. To deal with this problem, a novel PSO variant with state-based adaptive velocity limit strategy (PSO-SAVL) is proposed. In the proposed PSO-SAVL, VL is adaptively adjusted based on the evolutionary state estimation (ESE) in which a high value of VL is set for global searching state and a low value of VL is set for local searching state. Besides that, limit handling strategies have been modified and adopted to improve the capability of avoiding local optima. The good performance of PSO-SAVL has been experimentally validated on a wide range of benchmark functions with 50 dimensions. The satisfactory scalability of PSO-SAVL in high-dimension and large-scale problems is also verified. Besides, the merits of the strategies in PSO-SAVL are verified in experiments. Sensitivity analysis for the relevant hyper-parameters in state-based adaptive VL strategy is conducted, and insights in how to select these hyper-parameters are also discussed.Comment: 33 pages, 8 figure

Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors

BackgroundIt has been reported recently that resveratrol preconditioning can protect the brain from ischemia–reperfusion injury. However, it was unclear whether resveratrol administration after stroke was beneficial to the delayed phases after focal cerebral ischemia injury. This study investigated the effects and possible protective mechanism of resveratrol on the delayed phase after focal cerebral ischemia injury in mice.MethodsMice were randomly assigned to five groups according to the time of administration of resveratrol. Control group mice received a corresponding volume of saline solution (0.9% NaCl) containing 20% hydroxypropyl h-cyclodextrin by gavage and were exposed to middle cerebral artery (MCA) occlusion and reperfusion injury. The treatment groups received resveratrol (50 mg/kg/d, gavage) until day 7. Ischemia group mice received their first dose 5 minutes before MCA ischemia, reperfusion group mice received their first dose 5 minutes before MCA reperfusion, first-day, group mice received their first dose 24 hours after MCA reperfusion, and third-day group mice received their first dose at 72 hours after MCA reperfusion. Brain injury was evaluated by triphenyltetrazolium chloride staining and neurologic examination 7 days after reperfusion. The microvascular cell number was examined with immunohistochemistry staining. Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) gene expression was investigated with reverse transcriptase-polymerase chain reaction and Western blot.ResultsThe mean neurologic scores and infarct volumes of the ischemia and reperfusion groups were lower than that of the control group at 7 days after MCA reperfusion (P < .05). Immunohistochemistry staining showed significantly less reduction in the number of microvessels in the cortical area of mice of the ischemia and reperfusion groups compared with controls. The ischemic hemispheres of the ischemia and reperfusion groups showed significantly (P < .05) elevated levels of protein of MMP-2 and VEGF.ConclusionsResveratrol administration by gavage provided an important neuroprotective effect on focal cerebral ischemic injury in the delayed phase. The elevated MMP-2 and VEGF levels might be important in the neuroprotective effect of resveratrol administration by inducing angiogenesis.Clinical RelevanceStrokes can induce infarction size or neurologic disability and cause brain injury in millions of people world wide each year. However, there is no approved therapy currently, and so it is necessary to develop new treatments in the field of primary and secondary stroke to improve the prognosis. This study identified the benefits of early administration of resveratrol by gavage in the delayed phases after focal cerebral ischemic injury and further supports the possible use of resveratrol as a therapeutic agent to ameliorate ischemic infarction. Resveratrol may thus be considered as a potential candidate in the armamentarium of drugs for the early treatment in patients who sustain a stroke

Data-Driven Modeling with Experimental Augmentation for the Modulation Strategy of the Dual-Active-Bridge Converter

For the performance modeling of power converters, the mainstream approaches are essentially knowledge-based, suffering from heavy manpower burden and low modeling accuracy. Recent emerging data-driven techniques greatly relieve human reliance by automatic modeling from simulation data. However, model discrepancy may occur due to unmodeled parasitics, deficient thermal and magnetic models, unpredictable ambient conditions, etc. These inaccurate data-driven models based on pure simulation cannot represent the practical performance in physical world, hindering their applications in power converter modeling. To alleviate model discrepancy and improve accuracy in practice, this paper proposes a novel data-driven modeling with experimental augmentation (D2EA), leveraging both simulation data and experimental data. In D2EA, simulation data aims to establish basic functional landscape, and experimental data focuses on matching actual performance in real world. The D2EA approach is instantiated for the efficiency optimization of a hybrid modulation for neutral-point-clamped dual-active-bridge (NPC-DAB) converter. The proposed D2EA approach realizes 99.92% efficiency modeling accuracy, and its feasibility is comprehensively validated in 2-kW hardware experiments, where the peak efficiency of 98.45% is attained. Overall, D2EA is data-light and can achieve highly accurate and highly practical data-driven models in one shot, and it is scalable to other applications, effortlessly.Comment: 11 page

HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way

<p>Abstract</p> <p>Background</p> <p>Because some of heat shock protein 90's (HSP90) clients are key cell cycle regulators, HSP90 inhibition can affect the cell cycle. Recently, celastrol is identified both as a novel inhibitor of HSP90 and as a potential anti-tumor agent. However, this agent's effects on the cell cycle are rarely investigated. In this study, we observed the effects of celastrol on the human monocytic leukemia cell line U937 cell cycle.</p> <p>Results</p> <p>Celastrol affected the proliferation of U937 in a dose-dependent way, arresting the cell cycle at G0/G1 with 400 nM doses and triggering cell death with doses above 1000 nM. Cell cycle arrest was accompanied by inhibition of HSP90 ATPase activity and elevation in HSP70 levels (a biochemical hallmark of HSP90 inhibition), a reduction in Cyclin D1, Cdk4 and Cdk6 levels, and a disruption of the HSP90/Cdc37/Cdk4 complex. The observed effects of celastrol on the U937 cell cycle were thiol-related, firstly because the effects could be countered by pre-loading thiol-containing agents and secondly because celastrol and thiol-containing agents could react with each other to form new compounds.</p> <p>Conclusions</p> <p>Our results disclose a novel action of celastrol-- causing cell cycle arrest at G0/G1 phase based upon thiol-related HSP90 inhibition. Our work suggests celastrol's potential in tumor and monocyte-related disease management.</p

Spatial Carrying Capacity and Sustainability: Cities, Basins, Regional Transformation

This chapter focuses on the spatial carrying capacity of different types of space units. Based on the characteristics of different units, it discusses how resource carrying capacity, environmental carrying capacity, ecological carrying capacity, and infrastructure carrying capacity together affect the spatial carrying capacity and allocation efficiency of space units. Cities need agglomeration of economic and demographic elements to expand the scale of spatial carrying capacity. Basins need to allocate water resources rationally under the condition of limited water resources for the sustainable development of river basin ecosystem. Regions need to explore regional comparative advantages and transformation paths from regional industries. The case studies discuss how the spatial carrying capacity of cities, river basins, and regional transformation adapt to environmental changes and the direction of carrying capacity improvement

Evidence for association between Disrupted-in-schizophrenia 1 (DISC1) gene polymorphisms and autism in Chinese Han population: a family-based association study

<p>Abstract</p> <p>Background</p> <p>Disrupted-in-Schizophrenia 1 (<it>DISC1</it>) gene is one of the most promising candidate genes for major mental disorders. In a previous study, a Finnish group demonstrated that <it>DISC1 </it>polymorphisms were associated with autism and Asperger syndrome. However, the results were not replicated in Korean population. To determine whether <it>DISC1 </it>is associated with autism in Chinese Han population, we performed a family-based association study between <it>DISC1 </it>polymorphisms and autism.</p> <p>Methods</p> <p>We genotyped seven tag single nucleotide polymorphisms (SNPs) in <it>DISC1</it>, spanning 338 kb, in 367 autism trios (singleton and their biological parents) including 1,101 individuals. Single SNP association and haplotype association analysis were performed using the family-based association test (FBAT) and Haploview software.</p> <p>Results</p> <p>We found three SNPs showed significant associations with autism (rs4366301: G > C, Z = 2.872, <it>p </it>= 0.004; rs11585959: T > C, Z = 2.199, <it>p </it>= 0.028; rs6668845: A > G, Z = 2.326, <it>p </it>= 0.02). After the Bonferroni correction, SNP rs4366301, which located in the first intron of <it>DISC1</it>, remained significant. When haplotype were constructed with two-markers, three haplotypes displayed significant association with autism. These results were still significant after using the permutation method to obtain empirical <it>p </it>values.</p> <p>Conclusions</p> <p>Our study provided evidence that the <it>DISC1 </it>may be the susceptibility gene of autism. It suggested <it>DISC1 </it>might play a role in the pathogenesis of autism.</p

Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes

BACKGROUND: Acute worsening of renal function, an independent risk factor for adverse outcomes in acute decompensated heart failure (ADHF), occurs as a consequence of new onset kidney injury (AKI) or acute deterioration of pre-existed chronic kidney disease (CKD) (acute-on-chronic kidney injury, ACKI). However, the possible difference in prognostic implication between AKI and ACKI has not been well established. METHODS: We studied all consecutive patients hospitalized with ADHF from 2003 through 2010 in Nanfang Hospital. We classified patients as with or without pre-existed CKD based on the mean estimated glomerular filtration rate (eGFR) over a six-month period before hospitalization. AKI and ACKI were defined by RIFLE criteria according to the increase of the index serum creatinine. RESULTS: A total of 1,005 patients were enrolled. The incidence of ACKI was higher than that of AKI. The proportion of patients with diuretic resistance was higher among patients with pre-existed CKD than among those without CKD (16.9% vs. 9.9%, P = 0.002). Compared with AKI, ACKI was associated with higher risk for in-hospital mortality, long hospital stay, and failure in renal function recovery. Pre-existed CKD and development of acute worsening of renal function during hospitalization were the independent risk factors for in-hospital death after adjustment by the other risk factors. The RIFLE classification predicted all-cause and cardiac mortality in both AKI and ACKI. CONCLUSIONS: Patients with ACKI were at greatest risk of adverse short-term outcomes in ADHF. Monitoring eGFR and identifying CKD should not be ignored in patients with cardiovascular disease